Kim Dong-Wook, Chung Hwa-Jin, Nose Katsuya, Maruyama Ikuro, Tani Tadato
Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Japan.
J Pharm Pharmacol. 2002 Apr;54(4):571-5. doi: 10.1211/0022357021778691.
We report here that the traditional Chinese formulation, Chaihu-jia-Longgu-Muli-tang (CLM), significantly inhibited the increase in intimal thickening in rat carotid artery injured by balloon endothelial denudation, which mimics many aspects of restenosis after percutaneous coronary intervention (PCI) in humans. CLM, Saiko-ka-Ryukotsu-Borei-to in Japanese, is commonly prescribed for symptoms accompanying hypertension and atherosclerosis in Japanese Kampo medical care. CLM administered orally 1 week before and 1, 4 and 8 weeks after balloon injury inhibited the increase in intimal area, intimal/medial ratio and stenosis ratio. To our knowledge, this is the first report demonstrating inhibitory effects of a traditional Chinese formulation on intimal thickening of carotid artery after balloon injury. It is worth noting that CLM maintained its inhibitory effect up to 8 weeks after balloon injury. The reduction in intimal thickening by CLM could have resulted from inhibition of intimal smooth muscle cell proliferation, which was assessed by immuno-histochemical analysis using monoclonal antibody against proliferating cell nuclear antigen. Therefore, CLM may be a favourable candidate for prevention of restenosis after PCI. Moreover CLM may have a therapeutic value in the prevention of atherosclerosis, because restenosis after PCI is considered to be an accelerated atherosclerosis.
我们在此报告,传统中药方剂柴胡加龙骨牡蛎汤(CLM)可显著抑制大鼠球囊内皮剥脱损伤颈动脉后内膜增厚的增加,该损伤模拟了人类经皮冠状动脉介入治疗(PCI)后再狭窄的多个方面。CLM在日本汉方医学中常用于治疗伴随高血压和动脉粥样硬化的症状,其在日语中称为柴胡加龙骨牡蛎汤。在球囊损伤前1周以及损伤后1、4和8周口服CLM,可抑制内膜面积、内膜/中膜比值和狭窄率的增加。据我们所知,这是首次报道一种传统中药方剂对球囊损伤后颈动脉内膜增厚具有抑制作用。值得注意的是,CLM在球囊损伤后长达8周都保持其抑制作用。CLM对内膜增厚的抑制作用可能是由于抑制了内膜平滑肌细胞增殖,这是通过使用抗增殖细胞核抗原单克隆抗体的免疫组织化学分析来评估的。因此,CLM可能是预防PCI后再狭窄的理想候选药物。此外,CLM在预防动脉粥样硬化方面可能具有治疗价值,因为PCI后再狭窄被认为是一种加速的动脉粥样硬化。